Concepedia

Douglas T. Golenbock

DT

Statistics

Publications

259

Citations

63K

H-Index

123

Active since

1987

Affiliations

University of Massachusetts Chan Medical School(Current)

Boston University

Boston Medical Center

Harvard University

Universidade Federal de Minas Gerais

Douglas T. Golenbock is an author at University of Massachusetts Chan Medical School specializing in innate immunity, life sciences, and immunology.

ORCID

Publications per year

1987–2024

259

Publications

259

NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice

Michael T. Heneka, Markus P. Kummer, Andrea Stutz et al. · Nature · 2012 · 2.9K citations · Full text

, , +14

IKKε and TBK1 are essential components of the IRF3 signaling pathway

Katherine A. Fitzgerald, Sarah M. McWhirter, Daniel C. Rowe et al. · Nature Immunology · 2003 · 2.7K citations

, , +6

The NALP3 inflammasome is involved in the innate immune response to amyloid-β

Annett Halle, Veit Hornung, Gabor C. Petzold et al. · Nature Immunology · 2008 · 2.4K citations · Full text

, , +13

Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction

Jesse C. Chow, Donna W. Young, Douglas T. Golenbock et al. · Journal of Biological Chemistry · 1999 · 2K citations · Full text

, , +17

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

Evelyn A. Kurt‐Jones, L. Popova, Laura Kwinn et al. · Nature Immunology · 2000 · 1.7K citations

, , +14

1–5 of 259